Product correctly added to cart.

Lamivudine

CAS 134678-17-4: Lamivudine

Description:Lamivudine is an antiretroviral medication primarily used in the treatment of HIV/AIDS and chronic hepatitis B infection. It belongs to the class of nucleoside reverse transcriptase inhibitors (NRTIs) and functions by inhibiting the reverse transcriptase enzyme, which is crucial for viral replication. The chemical formula of Lamivudine is C8H11N3O3S, and it features a thiophenecarboxamide structure, which contributes to its pharmacological activity. Lamivudine is typically administered orally and is well-absorbed in the gastrointestinal tract, with a favorable safety profile. Common side effects may include headache, fatigue, and gastrointestinal disturbances. It is important to note that Lamivudine is often used in combination with other antiretroviral agents to enhance efficacy and reduce the risk of resistance. The substance is classified as a prescription medication and is included in various treatment guidelines for managing HIV and hepatitis B. Its effectiveness and safety have been well-documented in clinical studies, making it a vital component of antiviral therapy.

Formula:C8H11N3O3S

InChI:InChI=1S/C8H11N3O3S/c9-5-1-2-11(8(13)10-5)6-4-15-7(3-12)14-6/h1-2,6-7,12H,3-4H2,(H2,9,10,13)/t6-,7+/m0/s1

InChI key:InChIKey=JTEGQNOMFQHVDC-NKWVEPMBSA-N

SMILES:O=C1N=C(N)C=CN1C2OC(SC2)CO

  • Synonyms:
  • (-) 2'-Deoxy-3'-thiacytidine
  • (-)-1-[(2R,5S)-2-(hydroxymethyl)-1,3-oxathiolan-5-yl]cystosine
  • (-)-2¢ -Deoxy-3¢ -Thiacytidine
  • (-)-Bch-189
  • (-)Ngpb-21
  • (2R-cis)-4-Amino-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl]-2(1H)-pyrimidinone
  • (2R-cis)-4-amino-1-
  • 1,3-Oxathiolane, 2(1H)-pyrimidinone deriv.
  • 2(1H)-Pyrimidinone, 4-amino-1-[(2R,5S)-2-(hydroxymethyl)-1,3-oxathiolan-5-yl]-
  • 2(1H)-Pyrimidinone,4-amino-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl]-,(2R-cis)-
  • See more synonyms
  • 2-Hydroxymethyl-5-(cytosin-1-yl)-1,3-oxathiolane
  • 3'-Thia-2',3'-Dideoxcytidine
  • 3TC
  • 3¢ -Thia-2¢ ,3¢ -Dideoxycytidine
  • 4-Amino-1-[(2R,5S)-2-(hydroxymethyl)-1,3-oxathiolan-5-yl]-2(1H)-pyrimidinone
  • 4-amino-1-[(2R,5S)-2-(hydroxymethyl)-1,3-oxathiolan-5-yl]pyrimidin-2(1H)-one
  • 4-amino-1-[(2S,5R)-2-(hydroxymethyl)-1,3-oxathiolan-5-yl]pyrimidin-2(1H)-one
  • <span class="text-smallcaps">L</span>-SddC
  • Epivir
  • Epivir HBV
  • Gr 109714X
  • Gr109714X
  • Hepitec
  • Heptodin
  • Heptovir
  • Hiviral
  • Lamidine
  • Lamivir
  • Virolam
  • Zeffix
  • Zefix
  • cis(-)-2-Hydroxymethyl-5-(cytosin-1-yl)-1,3-oxathiolane
  • β-<span class="text-smallcaps">L</span>-2′,3′-Dideoxy-3′-thiacytidine
  • β-<span class="text-smallcaps">L</span>-3′-Thia-2′,3′-dideoxycytidine
  • 3¢-thia-2¢,3¢-dideoxycytidine
  • (-)-2¢-deoxy-3¢-thiacytidine
Sort by


See more categories

This search does not contain any category.

products per page. Found 27 products.

discount label

Lamivudine Mono POC Impurity

CAS:134678-17-4

Ref: 4Z-L-2017

5mgTo inquire
10mgTo inquire
25mgTo inquire
50mgTo inquire
100mgTo inquire
Estimated delivery in United States, on Friday 16 May 2025
discount label

Lamivudine

CAS:134678-17-4

Ref: TM-T0682

50mg58.00 €
100mg87.00 €
500mg180.00 €
1mL*10mM (DMSO)55.00 €
Estimated delivery in United States, on Friday 16 May 2025
discount label

Lamivudine-13C1,d2

Controlled Product
CAS:134678-17-4

Ref: TR-L172503

1mg464.00 €
10mg3,110.00 €
Estimated delivery in United States, on Monday 19 May 2025
discount label

Lamivudine

Controlled Product
CAS:134678-17-4

Ref: TR-L172500

25mg118.00 €
50mg128.00 €
100mg149.00 €
Estimated delivery in United States, on Monday 19 May 2025
discount label

Lamivudine

CAS:134678-17-4

Ref: 3D-NL06295

25g355.00 €
50g510.00 €
100g790.00 €
250g1,240.00 €
500g1,659.00 €
Estimated delivery in United States, on Tuesday 20 May 2025
discount label

Lamivudine - Bio-X ™

CAS:134678-17-4

Ref: 3D-BL164607

10mg147.00 €
Estimated delivery in United States, on Tuesday 20 May 2025
discount label

Lamivudine Dimer

Controlled Product
CAS:134678-17-4

Ref: TR-L172480

100mg2,353.00 €
Estimated delivery in United States, on Friday 20 Jun 2025
Welcome to CymitQuimica!We use cookies to enhance your visit. We do not include advertising.

Please see our Cookies Policy for more details or adjust your preferences in "Settings".